Adjunctive therapy after reperfusion therapy in acute myocardial infarction

Related Experiment Video

Updated: Oct 29, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

D L Dries1, A J Solomon, B J Gersh

  • 1Division of Cardiology, Georgetown University Hospital, Washington, D.C., USA.

Clinical Cardiology
|June 19, 1998
PubMed

Insights

This review examines additional medications that improve outcomes for acute myocardial infarction patients receiving thrombolytic therapy. It analyzes benefits of beta blockers, nitrates, ACE inhibitors, and magnesium alongside reperfusion treatments.

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Background:

  • Acute myocardial infarction (AMI) treatment has improved with thrombolytic therapy to restore blood flow.
  • Adjunctive pharmacologic therapies are crucial, but data often predates widespread reperfusion strategies.

Purpose of the Study:

  • To review the incremental benefits of specific adjunctive pharmacologic therapies in the thrombolytic era for AMI.
  • To evaluate the role of beta blockers, nitrates, angiotensin-converting enzyme inhibitors, and magnesium when used with thrombolysis.

Main Methods:

  • Literature review of clinical trial data on adjunctive pharmacologic therapies in AMI.
  • Analysis focused on studies involving thrombolytic therapy and reperfusion.

Main Results:

  • Beta blockers, nitrates, ACE inhibitors, and magnesium show potential incremental benefits when added to thrombolytic therapy.
  • Evidence synthesis to guide clinical practice in the context of reperfusion therapy.

Conclusions:

  • Adjunctive pharmacologic agents offer significant benefits in managing AMI patients undergoing thrombolysis.
  • Further research may refine optimal combination strategies for reperfusion therapy.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...